India’s Precision Medicine: A Vision Hindered by Biobank Regulations

Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.

Organ-on-chip device Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.

The Promise of Precision Medicine

In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.

India’s Growing Market

The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.

The Biobank Conundrum

Biobank While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.

A Path Forward

To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.

Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The AI Tipping Point: How Artificial Intelligence Is Rewriting the Real Estate Playbook

Artificial intelligence has shifted from a novelty to a defining force in real estate, transforming everything from listing creation to virtual staging while raising new legal and ethical risks. As AI adoption accelerates, experts warn that the agents who embrace automation and new tools now will gain a major competitive edge, while those who delay could fall behind in a rapidly evolving industry.

Want Job Security in the Age of AI? Get a State License

As AI and automation reshape the workforce, one form of career protection remains as powerful as ever: earning a state license. From real estate to trades to finance, licensed professionals stay in high demand because their work requires proven competence, accountability and human judgment—qualities technology can enhance but never replace. With trade enrollment surging, investor interest growing and licensing on the rise across the country, credentials have become a reliable path to stability, mobility and long-term earning potential.

AI Tools Are Transforming Agent‑Buyer Connections Ahead of 2026

A new wave of AI platforms is redefining how real estate agents identify buyer intent, spark conversations, and nurture relationships. From conversational home search engines to predictive opportunity alerts and relationship‑intelligence systems, these tools are helping agents connect sooner and smarter—reshaping daily workflows as the 2026 market approaches.

Texas Investors Fuel San Francisco’s Real Estate Revival

Texas money is riding hard into San Francisco, snapping up distressed downtown buildings at prices not seen in decades. From Union Square to California Street, major players like Lone Star Funds are betting big on the city’s rebound, signaling that the market may have finally hit bottom and that a new wave of opportunity is taking shape for savvy real estate professionals nationwide.

Holiday Spending Hits $1 Trillion—But CRE Experts Warn It May Be an Illusion

The 2025 holiday season is expected to break the $1 trillion sales mark, but economists say the milestone masks deeper consumer caution, income‑driven spending gaps, and weakening unit sales. Urban Land Magazine’s latest analysis shows how these mixed signals are shaping a selective, uneven landscape for U.S. commercial real estate heading into 2026—where strong locations thrive, weaker assets struggle, and affluent shoppers continue to dictate market performance.

Housing Market Predictions for 2026: Are Home Prices Finally Ready to Cool Off?

As 2025 ends, the housing market is inching toward balance with slower price growth, rising inventory, and steadier mortgage rates. Experts predict modest 1% to 2% home‑price growth in 2026—not a crash, but a calmer, more predictable market shaped by regional differences. With the Fed easing rates and inventory climbing in key cities, 2026 may become the most buyer‑friendly year in recent memory, especially for those prepared to act when the right home appears.